+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Onychomycosis Treatment Market by Drug Type (Combination Therapy, Laser Therapy, Oral Therapy), Active Ingredient (Amorolfine, Ciclopirox, Efinaconazole), Formulation, Distribution Channel, Treatment Setting, Age Group, Gender, Disease Severity - Global Forecast 2025-2030- Product Image
Onychomycosis Treatment Market by Drug Type (Combination Therapy, Laser Therapy, Oral Therapy), Active Ingredient (Amorolfine, Ciclopirox, Efinaconazole), Formulation, Distribution Channel, Treatment Setting, Age Group, Gender, Disease Severity - Global Forecast 2025-2030- Product Image
Sale

Onychomycosis Treatment Market by Drug Type (Combination Therapy, Laser Therapy, Oral Therapy), Active Ingredient (Amorolfine, Ciclopirox, Efinaconazole), Formulation, Distribution Channel, Treatment Setting, Age Group, Gender, Disease Severity - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5460360
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Onychomycosis Treatment Market is undergoing significant transformation as advances in therapeutic modalities, diagnostics, and digital healthcare disrupt conventional management strategies for nail fungal infections. As clinicians, manufacturers, and payers seek more effective and accessible solutions, onychomycosis care increasingly reflects both clinical complexity and evolving market dynamics.

Market Snapshot: Growth Trajectory in the Onychomycosis Treatment Market

The Onychomycosis Treatment Market grew from USD 2.09 billion in 2024 to USD 2.29 billion in 2025. It is expected to continue growing at a CAGR of 9.17%, reaching USD 3.55 billion by 2030. This upward trend is propelled by chronic disease prevalence, expanding patient populations, and intensifying demand for differentiated care options. Industry stakeholders are navigating a marketplace reshaped by evolving clinical requirements, technology-driven solutions, and heightened supply chain considerations.

Scope & Segmentation: Unpacking Market Structure and Strategic Levers

Thorough analysis of the market reveals multiple segmentation layers and therapeutic approaches that foster targeted product development and tailored delivery. This report includes:

  • Drug Types: Combination therapy, laser therapy, oral therapy, and topical therapy address diverse clinical needs.
  • Active Ingredients: Amorolfine, ciclopirox, efinaconazole, fluconazole, itraconazole, tavaborole, and terbinafine underpin treatment portfolios.
  • Formulations: Cream, gel, nail lacquer, solution, and tablet/capsule variants support patient compliance and optimize application.
  • Distribution Channels: Hospital pharmacies, online pharmacies, and retail pharmacists mediate access across key segments.
  • Treatment Settings: Home care, inpatient settings, and outpatient clinics represent varying care pathways.
  • Age Groups: 18 to 65 years, above 65 years, and below 18 years reflect demographic nuances in therapy adoption.
  • Gender: Female and male subgroups each present unique tolerability profiles and risk factors.
  • Disease Severity: Mild to moderate, recurrent, and severe onychomycosis demand tailored regimens and monitoring.
  • Regions: Americas, Europe, Middle East & Africa, Asia-Pacific; sub-regional detail encompasses the United States (including key states), Canada, Mexico, Brazil, Argentina, UK, Germany, France, multiple EMEA markets, China, India, Japan, Australia, and Southeast Asia.
  • Company Developments: Novartis, Pfizer, Bausch Health, Bayer, Sanofi, Galderma, Johnson & Johnson, Teva, Viatris, and LEO Pharma drive innovation and commercial activity.

Key Takeaways for Senior Decision-Makers

  • Complexity in onychomycosis management extends beyond clinical efficacy; decision-makers must consider patient adherence, recurrence risk, and psychosocial impacts.
  • Emergent treatment technologies include next-generation topical formulations, laser-assisted therapies, and digital health solutions that enable remote monitoring and adherence support.
  • Collaborative partnerships between pharma firms and device manufacturers give rise to integrated offerings and data-driven regimen optimization.
  • Personalized medicine is gaining traction, as biomarker research informs stratified therapeutic approaches to enhance real-world effectiveness.
  • Distribution strategies now cater to digitally engaged consumers, with online pharmacies and telemedicine platforms expanding market reach and patient engagement.
  • Competitive positioning depends on portfolio diversification, robust supply chain strategies, and the ability to adapt to changing regulatory and policy landscapes.

Tariff Impact: Navigating the 2025 U.S. Trade Policy Environment

The introduction of new United States tariffs in 2025 has influenced supply chains for antifungal agents and medical devices. Manufacturers are reevaluating sourcing and supplier networks to offset increased import duties, while distributors and pharmacies respond with contract renegotiations and inventory adjustments. These shifts impact pricing models and access, especially where reimbursement is sensitive to cost changes. Proactive engagement in scenario planning and domestic production partnerships is key to maintaining stable access and competitive pricing.

Methodology & Data Sources

This analysis is built on structured primary and secondary research. Industry insights come from in-depth interviews with leading dermatologists, pharmacologists, and supply chain specialists, complemented by reviews of clinical data, regulatory filings, and expert panels. Systematic data triangulation and rigorous quality control procedures uphold the reliability and relevance of findings.

Why This Report Matters

  • Enables strategic alignment by mapping therapy trends to real-world patient and regional needs.
  • Offers actionable intelligence for investment, R&D, and market entry decisions based on competitive and regulatory developments.
  • Equips decision-makers to build resilient supply chains and optimize distribution channels amid evolving policy landscapes.

Conclusion

The onychomycosis treatment market is shaped by a convergence of clinical innovation, regulatory shifts, and digital transformation. Stakeholders equipped with tailored insights can better navigate risks, capitalize on new opportunities, and drive improved patient outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of laser-based onychomycosis treatments with improved efficacy and reduced recurrence
5.2. Rising utilization of topical antifungal nail lacquers formulated with multitarget nanoparticle carriers to enhance penetration and efficacy
5.3. Growing interest in oral antifungal agents with improved safety profiles and shorter treatment duration to address patient compliance
5.4. Integration of teledermatology platforms for remote diagnosis and management of onychomycosis to expand patient access to specialists
5.5. Development of gene expression biomarkers to predict treatment response and personalize onychomycosis therapy based on fungal pathogen profiling
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Onychomycosis Treatment Market, by Drug Type
8.1. Introduction
8.2. Combination Therapy
8.3. Laser Therapy
8.4. Oral Therapy
8.5. Topical Therapy
9. Onychomycosis Treatment Market, by Active Ingredient
9.1. Introduction
9.2. Amorolfine
9.3. Ciclopirox
9.4. Efinaconazole
9.5. Fluconazole
9.6. Itraconazole
9.7. Tavaborole
9.8. Terbinafine
10. Onychomycosis Treatment Market, by Formulation
10.1. Introduction
10.2. Cream
10.3. Gel
10.4. Nail Lacquer
10.5. Solution
10.6. Tablet Capsule
11. Onychomycosis Treatment Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Onychomycosis Treatment Market, by Treatment Setting
12.1. Introduction
12.2. Home Care
12.3. Hospital Inpatient
12.4. Outpatient Clinic
13. Onychomycosis Treatment Market, by Age Group
13.1. Introduction
13.2. 18 To 65 Years
13.3. Above 65 Years
13.4. Below 18 Years
14. Onychomycosis Treatment Market, by Gender
14.1. Introduction
14.2. Female
14.3. Male
15. Onychomycosis Treatment Market, by Disease Severity
15.1. Introduction
15.2. Mild To Moderate
15.3. Recurrent
15.4. Severe
16. Americas Onychomycosis Treatment Market
16.1. Introduction
16.2. United States
16.3. Canada
16.4. Mexico
16.5. Brazil
16.6. Argentina
17. Europe, Middle East & Africa Onychomycosis Treatment Market
17.1. Introduction
17.2. United Kingdom
17.3. Germany
17.4. France
17.5. Russia
17.6. Italy
17.7. Spain
17.8. United Arab Emirates
17.9. Saudi Arabia
17.10. South Africa
17.11. Denmark
17.12. Netherlands
17.13. Qatar
17.14. Finland
17.15. Sweden
17.16. Nigeria
17.17. Egypt
17.18. Turkey
17.19. Israel
17.20. Norway
17.21. Poland
17.22. Switzerland
18. Asia-Pacific Onychomycosis Treatment Market
18.1. Introduction
18.2. China
18.3. India
18.4. Japan
18.5. Australia
18.6. South Korea
18.7. Indonesia
18.8. Thailand
18.9. Philippines
18.10. Malaysia
18.11. Singapore
18.12. Vietnam
18.13. Taiwan
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. Novartis AG
19.3.2. Pfizer Inc.
19.3.3. Bausch Health Companies Inc.
19.3.4. Bayer AG
19.3.5. Sanofi S.A.
19.3.6. Galderma S.A.
19.3.7. Johnson & Johnson Services, Inc.
19.3.8. Teva Pharmaceutical Industries Ltd.
19.3.9. Viatris Inc.
19.3.10. LEO Pharma A/S
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. ONYCHOMYCOSIS TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2024 VS 2030 (%)
FIGURE 20. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. ONYCHOMYCOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. ONYCHOMYCOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 31. ONYCHOMYCOSIS TREATMENT MARKET: RESEARCHAI
FIGURE 32. ONYCHOMYCOSIS TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 33. ONYCHOMYCOSIS TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 34. ONYCHOMYCOSIS TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ONYCHOMYCOSIS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY LASER THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ORAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ORAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TOPICAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TOPICAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AMOROLFINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AMOROLFINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY CICLOPIROX, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY CICLOPIROX, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY EFINACONAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY EFINACONAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FLUCONAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FLUCONAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ITRACONAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ITRACONAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TAVABOROLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TAVABOROLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TERBINAFINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TERBINAFINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY CREAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY CREAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY NAIL LACQUER, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY NAIL LACQUER, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TABLET CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TABLET CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY HOSPITAL INPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY HOSPITAL INPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY OUTPATIENT CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY OUTPATIENT CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY 18 TO 65 YEARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY 18 TO 65 YEARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ABOVE 65 YEARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ABOVE 65 YEARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY BELOW 18 YEARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY BELOW 18 YEARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FEMALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FEMALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY MALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY MALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY MILD TO MODERATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY MILD TO MODERATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY RECURRENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY RECURRENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY SEVERE, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY SEVERE, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 121. CANADA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 122. CANADA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 123. CANADA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 124. CANADA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 125. CANADA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 126. CANADA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 127. CANADA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. CANADA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. CANADA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 130. CANADA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 131. CANADA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 132. CANADA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 133. CANADA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 134. CANADA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 135. CANADA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 136. CANADA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 137. MEXICO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 138. MEXICO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 139. MEXICO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 140. MEXICO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 141. MEXICO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 142. MEXICO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 143. MEXICO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. MEXICO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. MEXICO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 146. MEXICO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 147. MEXICO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 148. MEXICO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 149. MEXICO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 150. MEXICO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 151. MEXICO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 152. MEXICO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 219. GERMANY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 220. GERMANY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 221. GERMANY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 222. GERMANY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 223. GERMANY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 224. GERMANY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 225. GERMANY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. GERMANY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. GERMANY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 228. GERMANY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 229. GERMANY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 230. GERMANY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 231. GERMANY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 232. GERMANY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 233. GERMANY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 234. GERMANY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 235. FRANCE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 236. FRANCE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 237. FRANCE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 238. FRANCE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 239. FRANCE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 240. FRANCE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 241. FRANCE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. FRANCE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. FRANCE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 244. FRANCE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 245. FRANCE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 246. FRANCE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 247. FRANCE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 248. FRANCE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 249. FRANCE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 250. FRANCE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 267. ITALY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 268. ITALY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 269. ITALY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 270. ITALY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 271. ITALY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 272. ITALY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 273. ITALY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. ITALY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. ITALY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 276. ITALY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 277. ITALY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 278. ITALY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 279. ITALY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 280. ITALY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 281. ITALY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 282. ITALY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 283. SPAIN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 284. SPAIN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 285. SPAIN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 286. SPAIN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 287. SPAIN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 288. SPAIN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 289. SPAIN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. SPAIN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. SPAIN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 292. SPAIN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 293. SPAIN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 294. SPAIN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 295. SPAIN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 296. SPAIN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 297. SPAIN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 298. SPAIN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 303. UNITED ARAB EMIRATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 305. UNITED ARAB EMIRATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. UNITED ARAB EMIRATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. UNITED ARAB EMIRATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 308. UNITED ARAB EMIRATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 316. SAUDI ARABIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 318. SAUDI ARABIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 320. SAUDI ARABIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 321. SAUDI ARABIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 322. SAUDI ARABIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 323. SAUDI ARABIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 324. SAUDI ARABIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-203

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Onychomycosis Treatment market report include:
  • Novartis AG
  • Pfizer Inc.
  • Bausch Health Companies Inc.
  • Bayer AG
  • Sanofi S.A.
  • Galderma S.A.
  • Johnson & Johnson Services, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • LEO Pharma A/S

Table Information

Report AttributeDetails
No. of Pages193
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.29 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.55 Billion
Compound Annual Growth Rate9.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Onychomycosis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To 2033 - Product Image

Onychomycosis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To 2033

  • Report
  • 178 Pages
  • Global
From
Onychomycosis Market Size, Share & Trends Analysis Report By Type (Distal Subungual Onychomycosis, White Superficial Onychomycosis, Proximal Subungual Onychomycosis), By Treatment (Oral, Topical), By Region, And Segment Forecasts, 2025 - 2033 - Product Image

Onychomycosis Market Size, Share & Trends Analysis Report By Type (Distal Subungual Onychomycosis, White Superficial Onychomycosis, Proximal Subungual Onychomycosis), By Treatment (Oral, Topical), By Region, And Segment Forecasts, 2025 - 2033

  • Report
  • 150 Pages
  • Global
From
Onychomycosis Treatment Market Report by Disease Type, Treatment Type, Drug Class, Distribution Channel, and Region 2025-2033 - Product Image

Onychomycosis Treatment Market Report by Disease Type, Treatment Type, Drug Class, Distribution Channel, and Region 2025-2033

  • Report
  • 143 Pages
  • Global
From
Onychomycosis Treatment Market Report 2025 - Product Image

Onychomycosis Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Global Onychomycosis Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global Onychomycosis Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 126 Pages
  • Global
From

About the Onychomycosis Drug Market

Onychomycosis is a fungal infection of the nail, which is a common condition affecting the toenails and fingernails. It is caused by a variety of fungi, including dermatophytes, yeasts, and molds. Treatment of onychomycosis is typically done with antifungal drugs, which are part of the infectious diseases drugs market. These drugs are used to treat a variety of fungal infections, including onychomycosis. The onychomycosis drug market is composed of a variety of antifungal drugs, including topical and oral medications. Topical medications are applied directly to the affected nail, while oral medications are taken by mouth. These drugs are used to treat the infection and prevent it from spreading. The onychomycosis drug market is highly competitive, with many companies offering a variety of antifungal drugs. Some of the major players in the market include Pfizer, Novartis, Merck, Johnson & Johnson, and GlaxoSmithKline. These companies offer a range of antifungal drugs, including topical and oral medications, to treat onychomycosis. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.